Morning Recap
Market Pulse: Crypto and precious metals are on a tear as Bitcoin’s bull cycle hits a late phase and gold climbs to fresh highs overnight.
Key Movers: Bitcoin’s profit-taking metrics spiked, but OG and ASTR ripped higher, while gold bulls unleashed fresh momentum as central banks feed stimulus fumes.
Macro & Politics: Financial nihilism among young adults intensifies, and Belgium’s Nyxoah is eyeing blockbuster growth with new Middle East centers in Dubai, Kuwait and Abu Dhabi.
What’s Next: Watch for crypto volatility spikes and Nyxoah announcements before today’s close.
Enhanced Market Commentary
Everyone’s overlooking the fragility in gold’s rally even as precious-metal bulls push prices to fresh intraday highs. The “Gold surges to new high as Wall Street predicts precious metal has room to run” piece on Yahoo Entertainment glosses over the fact that central bank stimulus can reverse on a dime—don’t be fooled when the next rate whisper bleeds into futures.
Consider how “Young adults embrace ‘financial nihilism' with risky crypto, stock bets as American dream feels unattainable” (CNBC) and Nyxoah’s Middle East expansion (GlobeNewswire) both hinge on a shift in confidence. When new entrants chase meme stocks and medtech devices across Dubai and Abu Dhabi with equal fervor, risk appetites converge in unexpected ways—this is a classic barometer of speculative fever.
Time to recalibrate: trim any runaway positions exposed to late-cycle crypto fatigue in “Bitcoin bull cycle enters ‘late phase’ as profit-taking metrics spike” (Cointelegraph) and scout for real growth signals, like Roche’s data on OCREVUS and fenebrutinib at ECTRIMS 2025 (GlobeNewswire)—that’s where genuine momentum lies.
📈 Breaking Financial News
FDA Approval Process for Medical Devices | 2-Day Online Training Course (Dec 2nd-3rd, 2025) with 12 CPD Hours | 510(k), IDE, PMA, HDE, and De Novo Demystified
This seminar offers key market opportunities by enhancing understanding of FDA device regulatory processes, including 510(k), IDE, PMA, HDE, and De Novo applications. It emphasizes pre-submission strategies, up-to-date regulatory changes, and practical applic…
Amneal Pharmaceuticals receives FDA approval for bimatoprost ophthalmic solution
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Roche presents new data for OCREVUS and fenebrutinib across broad patient populations at ECTRIMS 2025
Basel, 24 September 2025 – Roche (SIX: RO, ROG; OTCQX: RHHBY) presents new data for OCREVUS® (ocrelizumab) and the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib at the 41st Congress of the European Committee for Treatment and Research …
Nyxoah Provides an Update on Expanded Middle East Presence
Nyxoah Provides an Update on Expanded Middle East Presence New Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region……
CNBC’s Jim Cramer pulled out his catheter in shock after GameStop rally, needed 24/7 security
The “Mad Money” host revealed the threats during an interview on Bloomberg’s “Odd Lots” podcast Monday.
I Never Thought My Private Messages Would See The Light Of Day
Ever since Nov. 4th, there's been a huge surge in one specific type of trading opportunity. Go here to see more of my private messages… and the 3-part plan my friends and I are using to go after incredible potential gains in 2025: Leaked Private Messages Reveal Tim's 2025 Trade Plan?
🔍 Market Analysis & Insights
CNBC’s Jim Cramer pulled out his catheter in shock after GameStop rally, needed 24/7 security
The “Mad Money” host revealed the threats during an interview on Bloomberg’s “Odd Lots” podcast Monday.
Bitcoin bull cycle enters ‘late phase’ as profit-taking metrics spike
Glassnode warns that Bitcoin profit-taking behavior mirrors past bull market cycle peaks. Should investors expect more all-time highs?
Gold surges to new high as Wall Street predicts precious metal has room to run
Gold surpassed $3,800 in intraday trading Tuesday. Wall Street sees further gains ahead.
Young adults embrace ‘financial nihilism' with risky crypto, stock bets as American dream feels unattainable
Young people are pushing typical investing strategies to the side, instead favoring higher-risk alternatives.
Disney Decides One Week Of Giving In To Fascism Was All It Could Handle For Now
Sinclair stations to bravely do fascism on their own for now.
Top Secret Facility in the New Mexico Desert…
Inside, scientists aren't studying weapons or viruses-they're exploring a far more alien technology that could change how wars are fought. This new technology could be unleashed as soon as July 15. Once you see it for yourself, you'll understand the urgency. Click here now to discover more.
💰 Investment Opportunities
Is it a Wise Move to Buy Liquidia Corp. (LQDA) Shares?
Arquitos Capital Management, an investment management firm, released its second-quarter 2025 investor letter. During the period, the fund delivered a net…
A Long Road to an RSV Antibody to Protect the Most Vulnerable
A tragic RSV vaccine trial in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in RSV immunization
Crypto Market Today: OG, ASTR Surge as Bitcoin Defends $112K
The crypto market regained poise in the past 24 hours, with market leader bitcoin defending support at $112,000.
Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
New program delivers TULSA Procedure’s precision treatment – minimal side effects, no overnight hospital stay – to Medicare patients across Texas TORONTO, Sept. 23, 2025 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Comp…)
Terrifying reason Trump killed the U.S. penny?
You see, the U.S. is facing a looming shortage that could cripple the economy with runaway inflation… and send one tiny clutch of investments soaring in the weeks ahead. Former White House Advisor, Jim Rickards, just came forward to share this startling story.